Financial Performance - Operating revenue increased by 118.78% to CNY 4,596,270.25 year-on-year[5] - Net profit attributable to shareholders was CNY -19,487,443.11, a decrease of 49.04% compared to the same period last year[5] - Basic earnings per share decreased by 44.44% to CNY -0.26[5] - The net profit attributable to shareholders was a loss of CNY 19,487,443.11, a decrease of 49.04% year-on-year, primarily due to increased personnel costs for technology and market investments[15] - The net loss for Q1 2021 was CNY 19,487,443.11, compared to a net loss of CNY 13,075,208.82 in Q1 2020, reflecting a deterioration of approximately 48.5%[29] - The company reported a total comprehensive income for Q1 2021 was reported at -15,670,583.91 RMB, compared to -11,324,562.32 RMB in Q1 2020, reflecting a worsening in overall financial performance[33] Cash Flow - Net cash flow from operating activities was CNY -26,716,015.04, a decline of 129.71% year-on-year[5] - Operating cash flow net amount was a negative CNY 26,716,015.04, primarily due to increased cash payments for goods[18] - The company reported a net cash flow from operating activities of -26,716,015.04 RMB in Q1 2021, compared to -11,630,310.05 RMB in Q1 2020, indicating a decline in operational cash flow[35] - The company experienced a significant increase in cash outflow for purchasing goods and services, which rose to 40,868,176.78 RMB in Q1 2021 from 2,830,164.61 RMB in Q1 2020[34] - The company reported a net cash flow from investing activities of -136,752,925.39 RMB in Q1 2021, compared to -220,500,000.00 RMB in Q1 2020, showing an improvement in investment cash flow[35] Assets and Liabilities - Total assets decreased by 4.00% to CNY 772,154,576.91 compared to the end of the previous year[5] - Cash and cash equivalents decreased by 43.58% to CNY 212,642,113.30, mainly due to the purchase of bank financial products[16] - Trade financial assets increased significantly by 3,376.62% to CNY 133,850,000.00, also attributed to bank financial product purchases[16] - Accounts receivable increased by 523.22% to CNY 6,175,060.80, mainly due to an increase in bank notes not yet due[16] - Inventory rose by 53.70% to CNY 56,176,058.62, driven by increased stock levels to meet project demands[16] - Total current assets decreased to ¥668,149,397.69 from ¥709,952,693.81, reflecting a reduction of about 5.8%[20] - Total liabilities decreased to ¥61,639,599.02 from ¥74,689,968.61, a reduction of about 17.5%[22] - Total equity attributable to shareholders decreased to ¥710,514,977.89 from ¥729,677,731.00, reflecting a decline of approximately 2.6%[22] Research and Development - Research and development expenses accounted for 249.10% of operating revenue, a decrease of 118.38 percentage points[7] - Research and development expenses increased by 66.38% to CNY 7,143,680.47, reflecting higher personnel costs in R&D[18] - Research and development expenses in Q1 2021 were CNY 7,143,680.47, which is a 66.5% increase from CNY 4,293,574.71 in Q1 2020[27] Shareholder Information - The total number of shareholders at the end of the reporting period was 4,863[11] - The top shareholder, Cheng Jiaming, holds 39.22% of the shares with 28,862,900 shares[11] Other Financial Metrics - The weighted average return on net assets was -2.71%, a decrease of 0.86 percentage points compared to the previous year[5] - The company reported a total of CNY 151,755.18 in non-recurring gains and losses[8] - The company recorded investment income of CNY 1,211,341.37 in Q1 2021, with no corresponding figure reported for Q1 2020[27] - Sales expenses for Q1 2021 were CNY 8,259,309.88, compared to CNY 4,536,137.39 in Q1 2020, marking an increase of approximately 82.5%[27] Future Guidance - The company has not provided guidance for future performance or strategic initiatives in the report[19]
兴图新科(688081) - 2021 Q1 - 季度财报